Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils von Neuhoff

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Plos One|September 13, 2012
Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinicNils von Neuhoff, Tonio Oumeraci, Thomas Wolf, et al.
European Journal of Haematology|August 13, 2025
Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10Emma Steidel, Eser Orhan, Mareike Rasche, et al.
Genes, Chromosomes & Cancer|March 29, 2012
Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutationsFelicitas Thol, Britta Kölking, Frederik Damm, et al.
Blood|June 19, 2004
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCRMatthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, et al.
British Journal of Haematology|September 22, 2005
Expression of the p75 neurotrophin receptor in acute leukaemiaGernot Beutel, Johann Meyer, Liping Ma, et al.
Cancers|May 14, 2022
Efficient Small Extracellular Vesicles (EV) Isolation Method and Evaluation of EV-Associated DNA Role in Cell-Cell Communication in CancerVenkatesh Kumar Chetty, Jamal Ghanam, Srishti Anchan, et al.
Blood|December 9, 2008
High-affinity neurotrophin receptors and ligands promote leukemogenesisZhixiong Li, Gernot Beutel, Mathias Rhein, et al.
Pediatric Blood & Cancer|January 24, 2017
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acidUrsula Creutzig, Michael N Dworzak, Konrad Bochennek, et al.
Biomedicines|July 27, 2022
Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study GroupMaddalena Benetton, Pietro Merli, Christiane Walter, et al.
Haematologica|May 10, 2007
Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomasTim Ripperger, Nils von Neuhoff, Kathrin Kamphues, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Plos One|September 13, 2012
Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinicNils von Neuhoff, Tonio Oumeraci, Thomas Wolf, et al.
European Journal of Haematology|August 13, 2025
Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10Emma Steidel, Eser Orhan, Mareike Rasche, et al.
Genes, Chromosomes & Cancer|March 29, 2012
Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutationsFelicitas Thol, Britta Kölking, Frederik Damm, et al.
Blood|June 19, 2004
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCRMatthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, et al.
British Journal of Haematology|September 22, 2005
Expression of the p75 neurotrophin receptor in acute leukaemiaGernot Beutel, Johann Meyer, Liping Ma, et al.
Cancers|May 14, 2022
Efficient Small Extracellular Vesicles (EV) Isolation Method and Evaluation of EV-Associated DNA Role in Cell-Cell Communication in CancerVenkatesh Kumar Chetty, Jamal Ghanam, Srishti Anchan, et al.
Blood|December 9, 2008
High-affinity neurotrophin receptors and ligands promote leukemogenesisZhixiong Li, Gernot Beutel, Mathias Rhein, et al.
Pediatric Blood & Cancer|January 24, 2017
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acidUrsula Creutzig, Michael N Dworzak, Konrad Bochennek, et al.
Biomedicines|July 27, 2022
Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study GroupMaddalena Benetton, Pietro Merli, Christiane Walter, et al.
Haematologica|May 10, 2007
Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomasTim Ripperger, Nils von Neuhoff, Kathrin Kamphues, et al.
Pageof 7